Harbor Capital Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History
Harbor Capital Advisors, Inc.
- $2.29 Billion
- Q4 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 27,150 shares of COLL stock, worth $893,506. This represents 0.03% of its overall portfolio holdings.
Number of Shares
27,150
Previous 23,498
15.54%
Holding current value
$893,506
Previous $908,000
14.32%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding COLL
# of Institutions
254Shares Held
36.9MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$191 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$86.7 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$85.2 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$77.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$54.5 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.12B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...